Fact CheckerSign in

NCT06440174Recruiting

Understanding the Variation of Modern Endoscopic Ultrasound Use in Patients With Oesophageal Cancer (VALUE)

Understanding the Variation of Modern Endoscopic Ultrasound Use in Patients With Oesophageal Cancer (VALUE): a Multi-methods Study

Source: ClinicalTrials.gov · Last updated 30 Apr 2026

Brief summary (registry, in English)

This is an observational trial that will look at patients undergoing endoscopic ultrasound (EUS) in patients with oesophageal cancer and to determine the proportion of cases in which EUS changes disease management in these patients.

Status (registry)
Recruiting
Study type
Observational
Enrollment
160 (estimated)
First submitted
8 May 2024
Start date
27 Jun 2024
Primary completion date
30 Jun 2026
Lead sponsor
University Hospital Southampton NHS Foundation Trust
NCT number
NCT06440174

What you commit to

  • Study type: Observational
  • Planned participants: 160
  • From 27 Jun 2024 to the primary completion date, 30 Jun 2026
  • 14 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Previous oesophagectomy or oesophageal radiotherapy
  • Concurrent malignancy e.g., second primary tumour

Other illness

  • Recurrent or residual disease
  • Distant metastatic disease detected before EUS.

Other

  • Unable to undergo EUS examination.
  • Other histopathological cell type

Who the study is looking for

  • Patients aged 16 or above with first diagnosis of biopsy-confirmed oesophageal cancer.
  • Referred for EUS examination as part of standard of care investigations.
  • Tumour location in the oesophagus, or gastro-oesophageal junction (Siewert types I-III)
  • MDT decision that patient is potentially curable with radical treatment (e.g., endoscopic treatment, surgery +/- neoadjuvant therapy, or definitive chemoradiotherapy)
  • Prior staging with CT and PET-CT
  • Eastern Cooperative Oncology Group (ECOG) performance status 0-2
  • Clinical staging of T1-T4, N0-N3, M0 disease
  • Adenocarcinoma or squamous cell carcinoma (SCC) histopathological cell type

Age in the registry: 16 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (14)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Cwm Taf UHB
Coordinator of this site? Confirm its status
AbercynonUnited KingdomRecruiting
Royal Bournemouth Hospital
Coordinator of this site? Confirm its status
BournemouthUnited KingdomTerminated
Cambridge University NHS Foundation Trust
Coordinator of this site? Confirm its status
CambridgeUnited KingdomRecruiting
Cardiff and Vale UHB
Coordinator of this site? Confirm its status
CardiffUnited KingdomRecruiting
Velindre University NHS Trust
Coordinator of this site? Confirm its status
CardiffUnited KingdomRecruiting
Glasgow Royal Infirmary
Coordinator of this site? Confirm its status
GlasgowUnited KingdomRecruiting
Castle Hill Hospital
Coordinator of this site? Confirm its status
HullUnited KingdomRecruiting
Guy's and St Thomas' NHS Foundation Trust
Coordinator of this site? Confirm its status
LondonUnited KingdomRecruiting
Imperial College Healthcare NHS Trust
Coordinator of this site? Confirm its status
LondonUnited KingdomRecruiting
Queen's Medical Centre, Nottingham
Coordinator of this site? Confirm its status
NottinghamUnited KingdomRecruiting
Salford Royal Hospital
Coordinator of this site? Confirm its status
SalfordUnited KingdomRecruiting
University Hospital Southampton
Coordinator of this site? Confirm its status
SouthamptonUnited KingdomRecruiting
Singleton Hospital, Swansea
Coordinator of this site? Confirm its status
SwanseaUnited KingdomRecruiting
Royal Cornwall Hospital
Coordinator of this site? Confirm its status
TruroUnited KingdomRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.